Drug development
Faron Pharmaceuticals develops prescription medicines, mainly for cancer and severe immune-related conditions, and advances them through lab work, clinical trials, and regulatory testing. The company focuses on its own d...
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Faron Pharmaceuticals is a drug development company focused on medicines that change how the immune system behaves in cancer and severe inflammation. Its main work is to discover and test new drug candidates, especially bexmarilimab, an immunotherapy aimed at helping the body’s own defenses attack tumors. The company is not a mass-market drug seller; it is a research-stage biotech trying to turn lab findings into approved medicines.
Because Faron does not yet have a broad portfolio of approved products, most of its money comes from outside capital, research collaborations, and potential licensing or commercial deals if its drug candidates succeed. In practice, its main “customers” are not patients buying a finished product today, but hospitals, physicians, and partner companies that would use or help develop its therapies in the future. The company’s value comes from advancing clinical programs through testing, regulatory review, and, if successful, eventual commercialization.
What makes Faron’s business different is that it sits at the risky, early end of the pharmaceutical value chain: it creates proprietary drug candidates rather than manufacturing generic medicines or selling established treatments. That means its business depends on scientific results, clinical trial progress, and partner interest, not on steady product sales. If one of its programs works, the company can earn money from drug sales, licensing, or partnerships tied to that medicine.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
New to Alpha Spread? Create free account
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more